exploring the use of 2D NMR methods at natural 13C abundance along with various chemometric techniques for detection of changes in higher order structure in antibody therapeutics, as well as to establish analytical similarity for comparability studies. Prior to joining Genentech, he has completed a B.S. in physics at the City College of New York, followed by completion of his Ph.D. in biophysical chemistry at Yale University, with an emphasis on using NMR relaxation methods to study functional conformational dynamics in enzymes.